Direct distinction of ibuprofen and flurbiprofen enantiomers by ion mobility mass spectrometry of their ternary complexes with metal cations and cyclodextrins in the gas phase
- 6 April 2021
- journal article
- research article
- Published by Wiley in Journal of Separation Science
- Vol. 44 (12) , 2474-2482
Abstract
Enantiomeric drugs are widely used and play important roles in pharmaceuticals. Ion mobility spectrometry coupled with mass spectrometry technology provides a unique method for distinguishing the enantiomeric drugs, enantiomeric identification, and quantitation in the gas phase. In this study, enantiomeric molecules of ibuprofen and flurbiprofen were clearly recognized by forming host–guest complex ions using trapped ion mobility time‐of‐flight mass spectrometry. Ternary complex ions can be produced easily by electrospray ionization of the mixed solutions of ibuprofen, cyclodextrins, and CaCl2, LiCl, or NaCl, as well as flurbiprofen, cyclodextrins, and CaCl2. The relative contents of different chiral ibuprofens in a mixed solution were also quantitatively measured. This new method is a simple, effective, and a convenient enantioselective analysis method.Keywords
This publication has 28 references indexed in Scilit:
- Enantioselective determination of (R)‐ and (S)‐lansoprazole in human plasma by chiral liquid chromatography with mass spectrometry and its application to a stereoselective pharmacokinetic studyJournal of Separation Science, 2015
- Improved ultra‐performance liquid chromatography with electrospray ionization quadrupole‐time‐of‐flight high‐definition mass spectrometry method for the rapid analysis of the chemical constituents of a typical medical formula: Liuwei Dihuang WanJournal of Separation Science, 2013
- Chiral Derivatizing Agents, Macrocycles, Metal Complexes, and Liquid Crystals for Enantiomer Differentiation in NMR Spectroscopy2013
- The Significance of Chirality in Drug Design and DevelopmentCurrent Topics in Medicinal Chemistry, 2011
- Development of Quality-By-Design Analytical MethodsJournal of Pharmaceutical Sciences, 2011
- Chiral molecular recognition for the detection and analysis of enantiomers by mass spectrometric methodsJournal of Separation Science, 2005
- Comparative Pharmacology of S(+)-Ibuprofen and (RS)-IbuprofenClinical Rheumatology, 2001
- Enantiomeric drug development: Issues, considerations, and regulatory requirementsJournal of Pharmaceutical Sciences, 2001
- Clinical Pharmacokinetics of Flurbiprofen and its EnantiomersClinical Pharmacokinetics, 1995
- FDA'S policy statement for the development of new stereoisomeric drugsChirality, 1992